Abstract
This publication is a review of the scientific monograph by I.V. Ponkina and A.A. Ponkina Pharmaceutical Law (Moscow: GEOTAR-Media, 2017).
 The author of the review offers conclusions about the uniqueness of the research conducted for Russian legal science and about its high relevance in the field of legislative developments and accepting urgent measures on the fact of the threat of the COVID-19 pandemic.
 The results of the research is the identification of a branch of pharmaceutical law in the Russia legal science and the possibility of legislative regulation of its unique legal elements in the field of production, use, quality control and safety of medicines, also in related branch of law, including intellectual property rights in the pharmaceutical field.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
